-
1
-
-
1542515092
-
Chronic hepatitis B: Update of recommendations
-
Lok AS, McMahon BJ. Chronic hepatitis B: update of recommendations. Hepatology 2004; 39: 857-861
-
(2004)
Hepatology
, vol.39
, pp. 857-861
-
-
Lok, A.S.1
McMahon, B.J.2
-
2
-
-
20444363583
-
Asian-Pacific consensus statement on the management of chronic hepatitis B: A 2005 update
-
Liaw YF, Leung N, Guan R, Lau GK, Merican I, McCaughan G, Gane E, Kao JH, Omata M. Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2005 update. Liver Int 2005; 25: 472-489
-
(2005)
Liver Int
, vol.25
, pp. 472-489
-
-
Liaw, Y.F.1
Leung, N.2
Guan, R.3
Lau, G.K.4
Merican, I.5
McCaughan, G.6
Gane, E.7
Kao, J.H.8
Omata, M.9
-
3
-
-
17544369393
-
Lamivudine treatment for decompensated cirrhosis resulting from chronic hepatitis B
-
Villeneuve JP, Condreay LD, Willems B, Pomier-Layrargues G, Fenyves D, Bilodeau M, Leduc R, Peltekian K, Wong F, Margulies M, Heathcote EJ. Lamivudine treatment for decompensated cirrhosis resulting from chronic hepatitis B. Hepatology 2000; 31: 207-210
-
(2000)
Hepatology
, vol.31
, pp. 207-210
-
-
Villeneuve, J.P.1
Condreay, L.D.2
Willems, B.3
Pomier-Layrargues, G.4
Fenyves, D.5
Bilodeau, M.6
Leduc, R.7
Peltekian, K.8
Wong, F.9
Margulies, M.10
Heathcote, E.J.11
-
4
-
-
0033929544
-
Lamivudine treatment in patients with severely decompensated cirrhosis due to replicating hepatitis B infection
-
Yao FY, Bass NM. Lamivudine treatment in patients with severely decompensated cirrhosis due to replicating hepatitis B infection. J Hepatol 2000; 33: 301-307
-
(2000)
J Hepatol
, vol.33
, pp. 301-307
-
-
Yao, F.Y.1
Bass, N.M.2
-
5
-
-
0033931789
-
Beneficial effects of lamivudine in hepatitis B virus-related decompensated cirrhosis
-
Kapoor D, Guptan RC, Wakil SM, Kazim SN, Kaul R, Agarwal SR, Raisuddin S, Hasnain SE, Sarin SK. Beneficial effects of lamivudine in hepatitis B virus-related decompensated cirrhosis. J Hepatol 2000; 33: 308-312
-
(2000)
J Hepatol
, vol.33
, pp. 308-312
-
-
Kapoor, D.1
Guptan, R.C.2
Wakil, S.M.3
Kazim, S.N.4
Kaul, R.5
Agarwal, S.R.6
Raisuddin, S.7
Hasnain, S.E.8
Sarin, S.K.9
-
6
-
-
0033732462
-
Clinical improvement in patients with decompensated liver disease caused by hepatitis B after treatment with lamidvudine
-
Sponseller CA, Bacon BR, Di Bisceglie AM. Clinical improvement in patients with decompensated liver disease caused by hepatitis B after treatment with lamidvudine. Liver Transpl 2000; 6: 715-720
-
(2000)
Liver Transpl
, vol.6
, pp. 715-720
-
-
Sponseller, C.A.1
Bacon, B.R.2
Di Bisceglie, A.M.3
-
7
-
-
0036096895
-
Effect of lamivudine treatment on survival of 309 North American patients awaiting liver transplantation for chronic hepatitis B
-
Fontana RJ, Keeffe EB, Carey W, Fried M, Reddy R, Kowdley KV, Soldevila-Pico C, McClure LA, Lok AS. Effect of lamivudine treatment on survival of 309 North American patients awaiting liver transplantation for chronic hepatitis B. Liver Transpl 2002; 8: 433-439
-
(2002)
Liver Transpl
, vol.8
, pp. 433-439
-
-
Fontana, R.J.1
Keeffe, E.B.2
Carey, W.3
Fried, M.4
Reddy, R.5
Kowdley, K.V.6
Soldevila-Pico, C.7
McClure, L.A.8
Lok, A.S.9
-
8
-
-
0034927065
-
Lamivudine treatment is beneficial in patients with severely decompensated cirrhosis and actively replicating hepatitis B infection awaiting liver transplantation: A comparative study using a matched, untreated cohort
-
Yao FY, Terrault NA, Freise C, Maslow L, Bass NM. Lamivudine treatment is beneficial in patients with severely decompensated cirrhosis and actively replicating hepatitis B infection awaiting liver transplantation: a comparative study using a matched, untreated cohort. Hepatology 2001; 34: 411-416
-
(2001)
Hepatology
, vol.34
, pp. 411-416
-
-
Yao, F.Y.1
Terrault, N.A.2
Freise, C.3
Maslow, L.4
Bass, N.M.5
-
9
-
-
0037232566
-
A United States compassionate use study of lamivudine treatment in nontransplantation candidates with decompensated hepatitis B virus-related cirrhosis
-
Hann HW, Fontana RJ, Wright T, Everson G, Baker A, Schiff ER, Riely C, Anschuetz G, Gardner SD, Brown N, Griffiths D. A United States compassionate use study of lamivudine treatment in nontransplantation candidates with decompensated hepatitis B virus-related cirrhosis. Liver Transpl 2003; 9: 49-56
-
(2003)
Liver Transpl
, vol.9
, pp. 49-56
-
-
Hann, H.W.1
Fontana, R.J.2
Wright, T.3
Everson, G.4
Baker, A.5
Schiff, E.R.6
Riely, C.7
Anschuetz, G.8
Gardner, S.D.9
Brown, N.10
Griffiths, D.11
-
10
-
-
1542388336
-
Clinical course of lamivudine monotherapy in patients with decompensated cirrhosis due to HBeAg negative chronic HBV infection
-
Manolakopoulos S, Karatapanis S, Elefsiniotis J, Mathou N, Vlachogiannakos J, Iliadou E, Kougioumtzan A, Economou M, Triantos C, Tzourmakliotis D, Avgerinos A. Clinical course of lamivudine monotherapy in patients with decompensated cirrhosis due to HBeAg negative chronic HBV infection. Am J Gastroenterol 2004; 99: 57-63
-
(2004)
Am J Gastroenterol
, vol.99
, pp. 57-63
-
-
Manolakopoulos, S.1
Karatapanis, S.2
Elefsiniotis, J.3
Mathou, N.4
Vlachogiannakos, J.5
Iliadou, E.6
Kougioumtzan, A.7
Economou, M.8
Triantos, C.9
Tzourmakliotis, D.10
Avgerinos, A.11
-
11
-
-
0025981670
-
Natural history and prognostic factors for chronic hepatitis type B
-
Fattovich G, Brollo L, Giustina G, Noventa F, Pontisso P, Alberti A, Realdi G, Ruol A. Natural history and prognostic factors for chronic hepatitis type B. Gut 1991; 32: 294-298
-
(1991)
Gut
, vol.32
, pp. 294-298
-
-
Fattovich, G.1
Brollo, L.2
Giustina, G.3
Noventa, F.4
Pontisso, P.5
Alberti, A.6
Realdi, G.7
Ruol, A.8
-
12
-
-
0023762809
-
The development of cirrhosis in patients with chronic type B hepatitis: A prospective study
-
Liaw YF, Tai DI, Chu CM, Chen TJ. The development of cirrhosis in patients with chronic type B hepatitis: a prospective study. Hepatology 1988; 8: 493-496
-
(1988)
Hepatology
, vol.8
, pp. 493-496
-
-
Liaw, Y.F.1
Tai, D.I.2
Chu, C.M.3
Chen, T.J.4
-
13
-
-
0024391690
-
Natural course after the development of cirrhosis in patients with chronic type B hepatitis: A prospective study
-
Liaw YF, Lin DY, Chen TJ, Chu CM. Natural course after the development of cirrhosis in patients with chronic type B hepatitis: a prospective study. Liver 1989; 9: 235-241
-
(1989)
Liver
, vol.9
, pp. 235-241
-
-
Liaw, Y.F.1
Lin, D.Y.2
Chen, T.J.3
Chu, C.M.4
-
14
-
-
0028896179
-
Occurrence of hepatocellular carcinoma and decompensation in western European patients with cirrhosis type B
-
The EUROHEP Study Group on Hepatitis B Virus and Cirrhosis
-
Fattovich G, Giustina G, Schalm SW, Hadziyannis S, Sanchez-Tapias J, Almasio P, Christensen E, Krogsgaard K, Degos F, Carneiro de Moura M. Occurrence of hepatocellular carcinoma and decompensation in western European patients with cirrhosis type B. The EUROHEP Study Group on Hepatitis B Virus and Cirrhosis. Hepatology 1995; 21: 77-82
-
(1995)
Hepatology
, vol.21
, pp. 77-82
-
-
Fattovich, G.1
Giustina, G.2
Schalm, S.W.3
Hadziyannis, S.4
Sanchez-Tapias, J.5
Almasio, P.6
Christensen, E.7
Krogsgaard, K.8
Degos, F.9
Carneiro de Moura, M.10
-
15
-
-
0034919416
-
Fatal submassive hepatic necrosis associated with tyrosine-methionine-aspartate-aspartate-motif mutation of hepatitis B virus after long-term lamivudine therapy
-
Kim JW, Lee HS, Woo GH, Yoon JH, Jang JJ, Chi JG, Kim CY. Fatal submassive hepatic necrosis associated with tyrosine-methionine-aspartate-aspartate-motif mutation of hepatitis B virus after long-term lamivudine therapy. Clin Infect Dis 2001; 31: 403-405
-
(2001)
Clin Infect Dis
, vol.31
, pp. 403-405
-
-
Kim, J.W.1
Lee, H.S.2
Woo, G.H.3
Yoon, J.H.4
Jang, J.J.5
Chi, J.G.6
Kim, C.Y.7
-
16
-
-
0036189437
-
Fatal hepatic failure after emergence of the hepatitis B virus mutant during lamivudine therapy in a patient with liver cirrhosis
-
Wang JH, Lu SN, Lee CM, Lee JF, Chou YP. Fatal hepatic failure after emergence of the hepatitis B virus mutant during lamivudine therapy in a patient with liver cirrhosis. Scand J Gastroenterol 2002; 37: 366-369
-
(2002)
Scand J Gastroenterol
, vol.37
, pp. 366-369
-
-
Wang, J.H.1
Lu, S.N.2
Lee, C.M.3
Lee, J.F.4
Chou, Y.P.5
-
17
-
-
2942739297
-
Fatal liver failure due to reactivation of lamivudine-resistant HBV mutant
-
Kagawa T, Watanabe N, Kanouda H, Takayama I, Shiba T, Kanai T, Kawazoe K, Takashimizu S, Kumaki N, Shimamura K, Matsuzaki S, Mine T. Fatal liver failure due to reactivation of lamivudine-resistant HBV mutant. World J Gastroenterol 2004; 10: 1686-1687
-
(2004)
World J Gastroenterol
, vol.10
, pp. 1686-1687
-
-
Kagawa, T.1
Watanabe, N.2
Kanouda, H.3
Takayama, I.4
Shiba, T.5
Kanai, T.6
Kawazoe, K.7
Takashimizu, S.8
Kumaki, N.9
Shimamura, K.10
Matsuzaki, S.11
Mine, T.12
-
18
-
-
0032926519
-
Quantitative detection of hepatitis B virus by transcription-mediated amplification and hybridization protection assay
-
Kamisango K, Kamogawa C, Sumi M, Goto S, Hirao A, Gonzales F, Yasuda K, Iino S. Quantitative detection of hepatitis B virus by transcription-mediated amplification and hybridization protection assay. J Clin Microbiol 1999; 37: 310-314
-
(1999)
J Clin Microbiol
, vol.37
, pp. 310-314
-
-
Kamisango, K.1
Kamogawa, C.2
Sumi, M.3
Goto, S.4
Hirao, A.5
Gonzales, F.6
Yasuda, K.7
Iino, S.8
-
19
-
-
0020448882
-
Adenine arabinoside 5′-monophosphate treatment of chronic type B hepatitis
-
Hoofnagle JH, Minuk GY, Dusheiko GM, Schafer DF, Johnson R, Straus S, Jones EA, Gerin JL, Ishak K. Adenine arabinoside 5′-monophosphate treatment of chronic type B hepatitis. Hepatology 1982; 2: 784-788
-
(1982)
Hepatology
, vol.2
, pp. 784-788
-
-
Hoofnagle, J.H.1
Minuk, G.Y.2
Dusheiko, G.M.3
Schafer, D.F.4
Johnson, R.5
Straus, S.6
Jones, E.A.7
Gerin, J.L.8
Ishak, K.9
-
20
-
-
0021849977
-
Randomised controlled trial of adenine arabinoside 5′-monophosphate (ARA-AMP) in chronic hepatitis B virus infection
-
Weller IV, Lok AS, Mindel A, Karayiannis P, Galpin S, Monjardino J, Sherlock S, Thomas HC. Randomised controlled trial of adenine arabinoside 5′-monophosphate (ARA-AMP) in chronic hepatitis B virus infection. Gut 1985; 26: 745-751
-
(1985)
Gut
, vol.26
, pp. 745-751
-
-
Weller, I.V.1
Lok, A.S.2
Mindel, A.3
Karayiannis, P.4
Galpin, S.5
Monjardino, J.6
Sherlock, S.7
Thomas, H.C.8
-
21
-
-
0024326016
-
Randomized controlled trial of adenine arabinoside 5′-monophosphate in chronic active hepatitis B: Comparison of the efficacy in heterosexual and homosexual patients
-
Marcellin P, Ouzan D, Degos F, Brechot C, Metman EH, Degott C, Chevalier M, Berthelot P, Trepo C, Benhamou JP. Randomized controlled trial of adenine arabinoside 5′-monophosphate in chronic active hepatitis B: comparison of the efficacy in heterosexual and homosexual patients. Hepatology 1989; 10: 328-331
-
(1989)
Hepatology
, vol.10
, pp. 328-331
-
-
Marcellin, P.1
Ouzan, D.2
Degos, F.3
Brechot, C.4
Metman, E.H.5
Degott, C.6
Chevalier, M.7
Berthelot, P.8
Trepo, C.9
Benhamou, J.P.10
-
22
-
-
0021328173
-
Randomized controlled trial of adenine arabinoside monophosphate for chronic type B hepatitis
-
Hoofnagle JH, Hanson RG, Minuk GY, Pappas SC, Schafer DF, Dusheiko GM, Straus SE, Popper H, Jones EA. Randomized controlled trial of adenine arabinoside monophosphate for chronic type B hepatitis. Gastroenterology 1984; 86: 150-157
-
(1984)
Gastroenterology
, vol.86
, pp. 150-157
-
-
Hoofnagle, J.H.1
Hanson, R.G.2
Minuk, G.Y.3
Pappas, S.C.4
Schafer, D.F.5
Dusheiko, G.M.6
Straus, S.E.7
Popper, H.8
Jones, E.A.9
-
23
-
-
0032499913
-
A one-year trial of lamivudine for chronic hepatitis B
-
Asia Hepatitis Lamivudine Study Group
-
Lai CL, Chien RN, Leung NW, Chang TT, Guan R, Tai DI, Ng KY, Wu PC, Dent JC, Barber J, Stephenson SL, Gray DF. A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group. N Engl J Med 1998; 339: 61-68
-
(1998)
N Engl J Med
, vol.339
, pp. 61-68
-
-
Lai, C.L.1
Chien, R.N.2
Leung, N.W.3
Chang, T.T.4
Guan, R.5
Tai, D.I.6
Ng, K.Y.7
Wu, P.C.8
Dent, J.C.9
Barber, J.10
Stephenson, S.L.11
Gray, D.F.12
-
24
-
-
0037221907
-
Histological outcome during long-term lamivudine therapy
-
Dienstag JL, Goldin RD, Heathcote EJ, Hann HW, Woessner M, Stephenson SL, Gardner S, Gray DF, Schiff ER. Histological outcome during long-term lamivudine therapy. Gastroenterology 2003; 124: 105-117
-
(2003)
Gastroenterology
, vol.124
, pp. 105-117
-
-
Dienstag, J.L.1
Goldin, R.D.2
Heathcote, E.J.3
Hann, H.W.4
Woessner, M.5
Stephenson, S.L.6
Gardner, S.7
Gray, D.F.8
Schiff, E.R.9
-
25
-
-
10744225554
-
Long-term safety of lamivudine treatment in patients with chronic hepatitis B
-
Lok AS, Lai CL, Leung N, Yao GB, Cui ZY, Schiff ER, Dienstag JL, Heathcote EJ, Little NR, Griffiths DA, Gardner SD, Castiglia M. Long-term safety of lamivudine treatment in patients with chronic hepatitis B. Gastroenterology 2003; 125: 1714-1722
-
(2003)
Gastroenterology
, vol.125
, pp. 1714-1722
-
-
Lok, A.S.1
Lai, C.L.2
Leung, N.3
Yao, G.B.4
Cui, Z.Y.5
Schiff, E.R.6
Dienstag, J.L.7
Heathcote, E.J.8
Little, N.R.9
Griffiths, D.A.10
Gardner, S.D.11
Castiglia, M.12
-
26
-
-
33644637056
-
Clinical and virological features of non-breakthrough and severe exacerbation due to lamivudine-resistant hepatitis B virus mutants
-
Suzuki F, Akuta N, Suzuki Y, Sezaki H, Arase Y, Hosaka T, Someya T, Kobayashi M, Saitoh S, Ikeda K, Kobayashi M, Matsuda M, Satoh J, Watahiki S, Kumada H. Clinical and virological features of non-breakthrough and severe exacerbation due to lamivudine-resistant hepatitis B virus mutants. J Med Virol 2006; 78: 341-352
-
(2006)
J Med Virol
, vol.78
, pp. 341-352
-
-
Suzuki, F.1
Akuta, N.2
Suzuki, Y.3
Sezaki, H.4
Arase, Y.5
Hosaka, T.6
Someya, T.7
Kobayashi, M.8
Saitoh, S.9
Ikeda, K.10
Kobayashi, M.11
Matsuda, M.12
Satoh, J.13
Watahiki, S.14
Kumada, H.15
-
27
-
-
0032880610
-
Novel patterns of amino acid mutations in the hepatitis B virus polymerase in association with resistance to lamivudine therapy in japanese patients with chronic hepatitis B
-
Ogata N, Fujii K, Takigawa S, Nomoto M, Ichida T, Asakura H. Novel patterns of amino acid mutations in the hepatitis B virus polymerase in association with resistance to lamivudine therapy in japanese patients with chronic hepatitis B. J Med Virol 1999; 59: 270-276
-
(1999)
J Med Virol
, vol.59
, pp. 270-276
-
-
Ogata, N.1
Fujii, K.2
Takigawa, S.3
Nomoto, M.4
Ichida, T.5
Asakura, H.6
-
28
-
-
14844329880
-
Long-term follow-up of chronic hepatitis B after the emergence of mutations in the hepatitis B virus polymerase region
-
Natsuizaka M, Hige S, Ono Y, Ogawa K, Nakanishi M, Chuma M, Yoshida S, Asaka M. Long-term follow-up of chronic hepatitis B after the emergence of mutations in the hepatitis B virus polymerase region. J Viral Hepat 2005; 12: 154-159
-
(2005)
J Viral Hepat
, vol.12
, pp. 154-159
-
-
Natsuizaka, M.1
Hige, S.2
Ono, Y.3
Ogawa, K.4
Nakanishi, M.5
Chuma, M.6
Yoshida, S.7
Asaka, M.8
-
29
-
-
0027402590
-
Fatal hepatic decompensation associated with interferon alfa. European concerted action on viral hepatitis (Eurohep)
-
Janssen HL, Brouwer JT, Nevens F, Sanchez-Tapias JM, Craxi A, Hadziyannis S. Fatal hepatic decompensation associated with interferon alfa. European concerted action on viral hepatitis (Eurohep). BMJ 1993; 306: 107-108
-
(1993)
BMJ
, vol.306
, pp. 107-108
-
-
Janssen, H.L.1
Brouwer, J.T.2
Nevens, F.3
Sanchez-Tapias, J.M.4
Craxi, A.5
Hadziyannis, S.6
-
30
-
-
0034235905
-
Adefovir dipivoxil for the treatment of lamivudine-resistant hepatitis B mutants
-
Perrillo R, Schiff E, Yoshida E, Statler A, Hirsch K, Wright T, Gutfreund K, Lamy P, Murray A. Adefovir dipivoxil for the treatment of lamivudine-resistant hepatitis B mutants. Hepatology 2000; 32: 129-134
-
(2000)
Hepatology
, vol.32
, pp. 129-134
-
-
Perrillo, R.1
Schiff, E.2
Yoshida, E.3
Statler, A.4
Hirsch, K.5
Wright, T.6
Gutfreund, K.7
Lamy, P.8
Murray, A.9
-
31
-
-
0037468406
-
Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B
-
Hadziyannis SJ, Tassopoulos NC, Heathcote EJ, Chang TT, Kitis G, Rizzetto M, Marcellin P, Lim SG, Goodman Z, Wulfsohn MS, Xiong S, Fry J, Brosgart CL. Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B. N Engl J Med 2003; 348: 800-807
-
(2003)
N Engl J Med
, vol.348
, pp. 800-807
-
-
Hadziyannis, S.J.1
Tassopoulos, N.C.2
Heathcote, E.J.3
Chang, T.T.4
Kitis, G.5
Rizzetto, M.6
Marcellin, P.7
Lim, S.G.8
Goodman, Z.9
Wulfsohn, M.S.10
Xiong, S.11
Fry, J.12
Brosgart, C.L.13
-
32
-
-
0037468421
-
Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B
-
Marcellin P, Chang TT, Lim SG, Tong MJ, Sievert W, Shiffman ML, Jeffers L, Goodman Z, Wulfsohn MS, Xiong S, Fry J, Brosgart CL. Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B. N Engl J Med 2003; 348: 808-816
-
(2003)
N Engl J Med
, vol.348
, pp. 808-816
-
-
Marcellin, P.1
Chang, T.T.2
Lim, S.G.3
Tong, M.J.4
Sievert, W.5
Shiffman, M.L.6
Jeffers, L.7
Goodman, Z.8
Wulfsohn, M.S.9
Xiong, S.10
Fry, J.11
Brosgart, C.L.12
-
33
-
-
26844500312
-
A dose-ranging study of the efficacy and tolerability of entecavir in lamivudine-refractory chronic hepatitis B patients
-
Chang TT, Gish RG, Hadziyannis SJ, Cianciara J, Rizzetto M, Schiff ER, Pastore G, Bacon BR, Poynard T, Joshi S, Klesczewski KS, Thiry A, Rose RE, Colonno RJ, Hindes RG. A dose-ranging study of the efficacy and tolerability of entecavir in lamivudine-refractory chronic hepatitis B patients. Gastroenterology 2005; 129: 1198-1209
-
(2005)
Gastroenterology
, vol.129
, pp. 1198-1209
-
-
Chang, T.T.1
Gish, R.G.2
Hadziyannis, S.J.3
Cianciara, J.4
Rizzetto, M.5
Schiff, E.R.6
Pastore, G.7
Bacon, B.R.8
Poynard, T.9
Joshi, S.10
Klesczewski, K.S.11
Thiry, A.12
Rose, R.E.13
Colonno, R.J.14
Hindes, R.G.15
-
34
-
-
33644818518
-
A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B
-
Chang TT, Gish RG, de Man R, Gadano A, Sollano J, Chao YC, Lok AS, Han KH, Goodman Z, Zhu J, Cross A, DeHertogh D, Wilber R, Colonno R, Apelian D. A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B. N Engl J Med 2006; 354: 1001-1010
-
(2006)
N Engl J Med
, vol.354
, pp. 1001-1010
-
-
Chang, T.T.1
Gish, R.G.2
de Man, R.3
Gadano, A.4
Sollano, J.5
Chao, Y.C.6
Lok, A.S.7
Han, K.H.8
Goodman, Z.9
Zhu, J.10
Cross, A.11
DeHertogh, D.12
Wilber, R.13
Colonno, R.14
Apelian, D.15
-
35
-
-
33644822860
-
Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B
-
Lai CL, Shouval D, Lok AS, Chang TT, Cheinquer H, Goodman Z, DeHertogh D, Wilber R, Zink RC, Cross A, Colonno R, Fernandes L. Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B. N Engl J Med 2006; 354: 1011-1020
-
(2006)
N Engl J Med
, vol.354
, pp. 1011-1020
-
-
Lai, C.L.1
Shouval, D.2
Lok, A.S.3
Chang, T.T.4
Cheinquer, H.5
Goodman, Z.6
DeHertogh, D.7
Wilber, R.8
Zink, R.C.9
Cross, A.10
Colonno, R.11
Fernandes, L.12
-
36
-
-
10644275213
-
Comparison of adefovir and tenofovir in the treatment of lamivudine-resistant hepatitis B virus infection
-
van Bommel F, Wunsche T, Mauss S, Reinke P, Bergk A, Schurmann D, Wiedenmann B, Berg T. Comparison of adefovir and tenofovir in the treatment of lamivudine-resistant hepatitis B virus infection. Hepatology 2004; 40: 1421-1425
-
(2004)
Hepatology
, vol.40
, pp. 1421-1425
-
-
van Bommel, F.1
Wunsche, T.2
Mauss, S.3
Reinke, P.4
Bergk, A.5
Schurmann, D.6
Wiedenmann, B.7
Berg, T.8
-
37
-
-
21844431630
-
Viral dynamics during tenofovir the rapy in patients infected with lamivudine-resistant hepatitis B virus mutants
-
van der Eijk AA, Hansen BE, Niesters HG, Janssen HL, van de Ende M, Schalm SW, de Man RA. Viral dynamics during tenofovir the rapy in patients infected with lamivudine-resistant hepatitis B virus mutants. J Viral Hepat 2005; 12: 364-372
-
(2005)
J Viral Hepat
, vol.12
, pp. 364-372
-
-
van der Eijk, A.A.1
Hansen, B.E.2
Niesters, H.G.3
Janssen, H.L.4
van de Ende, M.5
Schalm, S.W.6
de Man, R.A.7
|